Bortelive 3.5mg Injection

      Bortlieva 3.5mg Injection contains Bortezomib, which is a proteasome inhibitor used in the treatment of certain types of cancers, most commonly multiple myeloma and mantle cell lymphoma. Bortezomib acts by preventing the breakdown of proteins by cell structures called proteasomes, which causes a buildup of proteins in cancer cells and ultimately results in their death.

Brand Name: Bortlieva

Composition: Bortezomib

Mechanism of Action:

Proteases are important in the breakdown of proteins that control cell development, and boratezomib suppresses their action. Protease inhibition causes damaged proteins to accumulate in the cell, which kills cancer cells and slows the growth of tumors.

Uses:

·       Multiple Myeloma

·       Mantle Cell Lymphoma

·       Waldenström's Macroglobulinemia

·       Amyloidosis

Side Effects:

·       Fatigue, weakness

·       Nausea

·       Fever

·       Anemia

·       Neutropenia

·       Thrombocytopenia

·       Numbness

·       Rash

·       Tumor Lysis Syndrome

·       Herpes Zoster Reactivation

Dosage and Administration:

The dosage of Bortlieva is typically based on body surface area and is administered as an injection either subcutaneously (under the skin) or intravenously (into a vein).

Safety Advise:

Heart  

Bortezomib can cause or worsen heart problems, especially in patients with pre-existing heart conditions. Kindly speak with your healthcare provider.

Liver  

Bortezomib can cause liver damage or elevate liver enzymes. Regular monitoring of liver function tests is advised. Kindly speak with your healthcare provider.

Lung  

Bortezomib can cause severe lung problems, including acute respiratory distress syndrome (ARDS) and interstitial lung disease. Kindly speak with your healthcare provider.

Pregnancy  

Bortezomib may cause harm to a developing fetus. Kindly speak with your healthcare provider.

Breastfeeding  

Bortlieva 3.5 Injection is dangerous to use while breastfeeding. Evidence points to the possibility of medication poisoning in the fetus. Kindly speak with your healthcare provider.

Alcohol  

When used with alcohol, Bortlieva 3.5 Injection may cause extreme sleepiness. Kindly speak with your healthcare provider.

Driving  

The negative effects of the Bortlieva 3.5 Injection may impair your driving skills. Your ability to drive may be impacted by fatigue, vertigo, fainting, or blurred vision from the Bortlieva 3.5 Injection. Kindly speak with your healthcare provider.

Storage:

Store the injection vial at 3.5-8°C (36-46°F) in a refrigerator. Protect from light and do not freeze.

How to use this Medication?

Bortezomib is available as a liquid solution that can be injected subcutaneously (beneath the skin) or into a vein. In a clinic or doctor's office, a nurse or doctor administers boratezamib. The disease you have, the other medications you take, and how well your body reacts to treatment will all affect your dose plan.

Throughout your therapy, make sure to let your doctor know how you are feeling. If you have side effects from bortezomib, your doctor may temporarily halt your therapy or lower your dosage. 

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details:
Name: Allieva Pvt. Ltd.
Address: Ahmedabad, Gujarat, India
Country of origin: India

Frequently Asked Questions (FAQs):

1. What is Bortlieva 3.5 mg Injection used for?
Bortlieva 3.5 mg Injection is used to treat certain blood cancers, such as multiple myeloma and mantle cell lymphoma. It should be used only under the supervision of a cancer specialist.

3.5. How is Bortlieva 3.5 mg Injection administered?
This medicine is given by a trained healthcare professional as directed by your doctor. Do not attempt to self-administer it.

3. What are the common side effects of Bortlieva 3.5 mg Injection?
Some patients may experience tiredness, nausea, diarrhea, constipation, loss of appetite, or tingling and numbness in the hands and feet. Inform your doctor if any side effects become troublesome.

4. Will I need any tests during treatment?
Yes. Your doctor may recommend regular blood tests and health check-ups to monitor your response to treatment and detect any side effects early.

5. What precautions should I take while receiving Bortlieva 3.5 mg Injection?
Tell your doctor about any existing medical conditions and all medicines you are taking. Always consult your doctor before starting or stopping any medication during treatment.